SBIR-STTR Award

QSAR Models: Human CYP450 Drug Metabolism and Kinetics
Award last edited on: 11/16/06

Sponsored Program
SBIR
Awarding Agency
NIH : NIGMS
Total Award Amount
$515,303
Award Phase
2
Solicitation Topic Code
-----

Principal Investigator
Kurt Enslein

Company Information

Enslein Research Inc

183 East Main Street Suite 1428
Rochester, NY 14604
   (585) 232-8160
   kenslein@enres.com
   www.enres.com
Location: Single
Congr. District: 25
County: Monroe

Phase I

Contract Number: 1R44GM068164-01A1
Start Date: 00/00/00    Completed: 00/00/00
Phase I year
2004
Phase I Amount
$103,924
The long-term objective of the proposed research is to provide computer-based tools to aid in the high-throughput screening of drug candidates, derived from combinatorial chemistry and similar techniques. The data for the QSAR models will be derived from human liver-based chromosome P450 enzymes. Three classes of models will be developed: 1. QSAR models for the estimation of Vmax and Km of various transformations. The Phase I application deals only with hydroxylation. 2. QSAR models for the estimation of probability of a compound being a substrate (or inhibitor) for a particular isozyme. The Phase I application deals only with CYP3A4. 3. QSAR models for intrinsic clearance, for various transformations. Again, the Phase I application deals only with hydroxylation. The data for the kinetic models will be derived from the literature; the data for the substrate probability models from a previously assembled database of enzyme-compound relationships. Statistical techniques will include stepwise and all-possible regressions, the kNN-QSAR program based on a nearest-neighbor algorithm, as well as well as regression based on adaptive splines.

Thesaurus Terms:
chemical structure function, computer simulation, computer system design /evaluation, cytochrome P450, drug metabolism, high throughput technology, hydroxylation, molecular dynamics chemical information system, chemical structure, combinatorial chemistry, enzyme substrate, isozyme, pharmacokinetics Internet

Phase II

Contract Number: 4R44GM068164-02
Start Date: 00/00/00    Completed: 00/00/00
Phase II year
2005
(last award dollars: 2006)
Phase II Amount
$411,379

The long-term objective of the proposed research is to provide computer-based tools to aid in the high-throughput screening of drug candidates, derived from combinatorial chemistry and similar techniques. The data for the QSAR models will be derived from human liver-based chromosome P450 enzymes. Three classes of models will be developed: 1. QSAR models for the estimation of Vmax and Km of various transformations. The Phase I application deals only with hydroxylation. 2. QSAR models for the estimation of probability of a compound being a substrate (or inhibitor) for a particular isozyme. The Phase I application deals only with CYP3A4. 3. QSAR models for intrinsic clearance, for various transformations. Again, the Phase I application deals only with hydroxylation. The data for the kinetic models will be derived from the literature; the data for the substrate probability models from a previously assembled database of enzyme-compound relationships. Statistical techniques will include stepwise and all-possible regressions, the kNN-QSAR program based on a nearest-neighbor algorithm, as well as well as regression based on adaptive splines.

Thesaurus Terms:
chemical structure function, computer simulation, computer system design /evaluation, cytochrome P450, drug metabolism, high throughput technology, hydroxylation, molecular dynamics chemical information system, chemical structure, combinatorial chemistry, enzyme substrate, isozyme, pharmacokinetics Internet